Compared with PBS and untreated controls, Bgrp78 cell injection resulted in an enhanced tumor progression (Figure 7B), PD‐L1 upregulation on intratumoral B cells and less tumor infiltration of effector CD4+ T cells (Figure 7C,D). The gene discussed is CD4; the disease is neoplasm.